~~<i id='1D54EEA0F1'><strike id='1D54EEA0F1'><tt id='1D54EEA0F1'><pre id='1D54EEA0F1'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：focus 2025-10-01 01:56:26 Page View：7

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ‘The Bear’ and hospitality in hospitals
Next article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

leisure time

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

0:50AnelectronicsignadvertisestheMegaMillionsandPowerBalljackpotamountsoutsideaconveniencestoreonAug

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

Trump Organization, Michael Cohen agree to settle million

5:55MichaelCohenspeakstoreportersonMarch15,2023,inNewYork.MaryAltaffer/AP,FILETheTrumpOrganizationan